Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors

被引：0
|
作者：
Samuel J. Reddick
Olivia Campagne
Jie Huang
Arzu Onar-Thomas
Alberto Broniscer
Amar Gajjar
Clinton F. Stewart
机构：
[1] St. Jude Children’s Research Hospital,Department of Pharmaceutical Sciences
[2] St. Jude Children’s Research Hospital,Department of Biostatistics
[3] St. Jude Children’s Research Hospital,Division of Neuro
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 84卷
关键词：
Erlotinib; Pharmacokinetics; Pediatrics; Toxicity; Brain tumors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：829 / 838
页数：9
相关论文
共 27 条
  • [21] Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children
    Fisher, PG
    Needle, MN
    Cnaan, A
    Zhao, HQ
    Geyer, JR
    Molloy, PT
    Goldwein, JW
    Herman-Liu, AB
    Phillips, PC
    CANCER, 1998, 83 (03) : 566 - 574
  • [22] MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children
    Joann L. Ater
    Jan van Eys
    Shiao Y. Woo
    Bartlett Moore III
    Donna R. Copeland
    Janet Bruner
    Journal of Neuro-Oncology, 1997, 32 : 243 - 252
  • [23] Safety and pharmacokinetics of intrathecal liposomal cytarabine (Depocyte®) in children 3 years of age with malignant brain tumors
    Peyrl, Andreas
    Sauermann, Robert
    Traunmueller, Friederike
    Azizi, Amedeo
    Slavc, Irene
    NEURO-ONCOLOGY, 2008, 10 (03) : 446 - 446
  • [24] The influence of age on the disposition of cyclophosphamide and its metabolites in infants and young children with brain tumors: A population pharmacokinetic analysis
    Maharaj, Anil R.
    Panetta, John C.
    Gajjar, Amar
    Stewart, Clinton F.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S21 - S21
  • [25] Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant
    Roberts, Jessica K.
    Birg, Anna V.
    Lin, Tong
    Daryani, Vinay M.
    Panetta, John C.
    Broniscer, Alberto
    Robinson, Giles W.
    Gajjar, Amar J.
    Stewart, Clinton F.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (07) : 1116 - 1122
  • [26] Clinical pharmacokinetics (PK) and safety of high-dose (HD) methotrexate (MTX) during induction therapy of pediatric patients younger than 3 years of age with primary brain tumors
    McKibbin, T.
    Tagen, M.
    Panetta, J. C.
    Ward, D.
    Gajjar, A. J.
    Wright, K. D.
    Broniscer, A.
    Stewart, C. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598
    Gu, Kenan
    Spitz, Robert
    Hammett, Erin
    Jaunarajs, Anna
    Ghazaryan, Varduhi
    Garvey, Edward P.
    Degenhardt, Thorsten
    MEDICAL MYCOLOGY, 2024, 62 (04)
123